Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Payables (2016 - 2025)

Historic Payables for HUTCHMED (China) (HCM) over the last 11 years, with Q2 2025 value amounting to $69.3 million.

  • HUTCHMED (China)'s Payables fell 77.0% to $69.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $69.3 million, marking a year-over-year decrease of 77.0%. This contributed to the annual value of $10.6 billion for FY2024, which is 2826.97% down from last year.
  • Per HUTCHMED (China)'s latest filing, its Payables stood at $69.3 million for Q2 2025, which was down 77.0% from $16.1 billion recorded in Q4 2024.
  • In the past 5 years, HUTCHMED (China)'s Payables registered a high of $16.1 billion during Q4 2024, and its lowest value of -$3.0 million during Q1 2021.
  • Moreover, its 5-year median value for Payables was $55.0 million (2021), whereas its average is $3.1 billion.
  • Per our database at Business Quant, HUTCHMED (China)'s Payables tumbled by 15677.31% in 2021 and then surged by 12969275.58% in 2023.
  • Quarter analysis of 5 years shows HUTCHMED (China)'s Payables stood at $9.6 million in 2021, then rose by 19.24% to $11.4 million in 2022, then surged by 129692.76% to $14.8 billion in 2023, then increased by 8.9% to $16.1 billion in 2024, then crashed by 99.57% to $69.3 million in 2025.
  • Its Payables was $69.3 million in Q2 2025, compared to $16.1 billion in Q4 2024 and $69.9 million in Q2 2024.